Skip to main content
. 2021 Jun 28;12:665493. doi: 10.3389/fphar.2021.665493

FIGURE 3.

FIGURE 3

MAPKs, NAMPT, and SIRT1 changes according to the group. (A) C26-induced cancer cachexia was associated either ERK and JNK activation, then NR administration significantly inactivated these cachexia-associated MAPKs. (B) NAMPT1 was significantly decreased in cancer cachexia group, suggesting incomplete conversion of NAD+ in cancer cachexia, whereas NR administration maintained NAMPT1 expression. (C) SIRT1 was significantly increased in cancer cachexia group, but not in the NR-treated group, suggesting that NR administration did not affect SIRT1-mediated muscle atrophy.